• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

Oct 22
1:00 pm - 2:00 pm CDT

Les Turner ALS Foundation: The Access for ALL in ALS Consortium

Oct 27
2:00 pm - 3:00 pm EDT

ALS Association Webinar: An Honest Look at Hospice and ALS

Nov 2
2:00 pm - 3:00 pm EST

ALS Association Webinar: Caregiving, Connection & Meaningful Moments Series

View Calendar

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Steve

    Steve

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Mark Miller, UK

    Mark Miller, UK

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Olga, Argentina

    Olga, Argentina

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Greg Heydet, USA

    Greg Heydet, USA

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Philip Brindle, England

    Philip Brindle, England

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Art Eggert, USA

    Art Eggert, USA

  • Susan Anderson, USA

    Susan Anderson, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Christian Bär, Germany

    Christian Bär, Germany

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Hollister

    Hollister
    hollister

  • David Hall, USA

    David Hall, USA

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login